Hitoshi Kawasuji

729 total citations
42 papers, 379 citations indexed

About

Hitoshi Kawasuji is a scholar working on Infectious Diseases, Epidemiology and Neurology. According to data from OpenAlex, Hitoshi Kawasuji has authored 42 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 15 papers in Epidemiology and 11 papers in Neurology. Recurrent topics in Hitoshi Kawasuji's work include SARS-CoV-2 and COVID-19 Research (17 papers), COVID-19 Clinical Research Studies (16 papers) and Long-Term Effects of COVID-19 (11 papers). Hitoshi Kawasuji is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (17 papers), COVID-19 Clinical Research Studies (16 papers) and Long-Term Effects of COVID-19 (11 papers). Hitoshi Kawasuji collaborates with scholars based in Japan and New Zealand. Hitoshi Kawasuji's co-authors include Yoshihiro Yamamoto, Akitoshi Ueno, Yuki Miyajima, Ippei Sakamaki, Yoshitomo Morinaga, Makito Kaneda, Yasutaka Fukui, Yoshihiro Yoshida, Hideki Tani and Yasuhiro Tsuji and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Hitoshi Kawasuji

35 papers receiving 375 citations

Peers

Countries citing papers authored by Hitoshi Kawasuji

Since Specialization

Citations

This map shows the geographic impact of Hitoshi Kawasuji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Kawasuji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Kawasuji more than expected).

Fields of papers citing papers by Hitoshi Kawasuji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Kawasuji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Kawasuji. The network helps show where Hitoshi Kawasuji may publish in the future.

Co-authorship network of co-authors of Hitoshi Kawasuji

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Kawasuji. A scholar is included among the top collaborators of Hitoshi Kawasuji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Kawasuji. Hitoshi Kawasuji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Refractory tenosynovitis caused by Mycobacterium virginiense required repeated debridement: A case report and literature review 2025 ·Diagnostic Microbiology and Infectious Disease ·Tomohiko Sekiguchi, Hitoshi Kawasuji, (unknown), (unknown), (unknown), (unknown), Kentaro Nagaoka, Yoshitomo Morinaga, Hideki Niimi, Yoshihiro Yamamoto	0
2	Effects of extended anaerobic antibiotic coverage on anaerobic bloodstream infection: A multisite retrospective study 2025 ·International Journal of Infectious Diseases ·Y Murai, Kentaro Nagaoka, Naoki Iwanaga, Hitoshi Kawasuji, Masayoshi Miura, (unknown), (unknown), Yukari Kato, Takahiro Takazono, Kosuke Kosai, Aki Sugano, Yoshitomo Morinaga, Kaori Tanaka, (unknown), Hiroshi Mukae, Yoshihiro Yamamoto	0
3	High feasibility of salivary therapeutic drug monitoring in linezolid, but lower feasibility in tedizolid: a single-dose study in healthy subjects and a monocentric prospective exploratory study in patients who received linezolid 2025 ·Journal of Antimicrobial Chemotherapy ·Hitoshi Kawasuji, Yasuhiro Tsuji, (unknown), Takahiko Aoyama, (unknown), (unknown), (unknown), (unknown), Makito Kaneda, (unknown), (unknown), Kentaro Nagaoka, Yoshihiro Yamamoto	0
4	The fatal case of “Pigmentibacter” bacteremia following aspiration pneumonia in elderly patient 2024 ·Journal of Infection and Chemotherapy ·(unknown), Hitoshi Kawasuji, Ryosuke Nakai, Hiroshi Yamada, Yoshihiro Yoshida, Hiroyuki Kawahara, Mai Suzuki, (unknown), (unknown), (unknown), Hideki Niimi, Yoshitomo Morinaga, Yoshihiro Yamamoto	0
5	Low pre-infection levels of neutralizing antibody in breakthrough infections after bivalent BA.4–5 vaccine and practical application of dried blood spots 2024 ·Vaccine ·Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Hiroshi Yamada, Yoshihiro Yoshida, (unknown), (unknown), (unknown), Makito Kaneda, (unknown), (unknown), Kentaro Nagaoka, Hideki Niimi, Yoshihiro Yamamoto	0
6	COVID-19 complicated with severe M1UK-lineage Streptococcus pyogenes infection in elderly patients: A report of two cases 2024 ·International Journal of Infectious Diseases ·Atsushi Kawaguchi, Kentaro Nagaoka, Hitoshi Kawasuji, (unknown), (unknown), (unknown), (unknown), Tomoaki Doi, Kazunori Oishi, Yoshihiro Yamamoto	5
7	Association between sore throat and early immune responses against COVID-19 before and after the emergence of the Omicron variant 2024 ·Annals of Translational Medicine ·(unknown), Kentaro Nagaoka, (unknown), Hitoshi Kawasuji, (unknown), Makito Kaneda, (unknown), Hideki Tani, Hideki Niimi, Yoshitomo Morinaga, Yoshihiro Yamamoto	0
8	Clinical phenotype of anaerobic bacteremia unaccompanied by detectable abscess lesion: a 10-year retrospective, multicenter, observational-cohort study 2024 ·Infection ·Kentaro Nagaoka, Naoki Iwanaga, (unknown), Hitoshi Kawasuji, Masayoshi Miura, Yukihiro Sato, Ito H, (unknown), Takahiro Takazono, Kosuke Kosai, Aki Sugano, Yoshitomo Morinaga, Katsunori Yanagihara, Hiroshi Mukae, Yoshihiro Yamamoto	1
9	Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5 2023 ·Microbiology Spectrum ·Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, (unknown), Hiroshi Yamada, Yoshihiro Yoshida, (unknown), Makito Kaneda, (unknown), (unknown), Akitoshi Ueno, Yuki Miyajima, Kentaro Nagaoka, Chikako Ono, Yoshiharu Matsuura, Hideki Niimi, Yoshihiro Yamamoto	12
10	Pulmonary abscess caused by Cladosporium cladosporioides after receiving outpatient chemotherapy 2023 ·Journal of Infection and Chemotherapy ·Makito Kaneda, Kentaro Nagaoka, Hitoshi Kawasuji, Kazuko Matsunaga, Minehiko Inomata, Yasuhiro Miyazaki, Akio Nakashima, Yoshiyuki Yamamoto	2
11	Dominant CT Patterns and Immune Responses during the Early Infection Phases of Different SARS-CoV-2 Variants 2023 ·Viruses ·Kentaro Nagaoka, Hitoshi Kawasuji, (unknown), (unknown), Makito Kaneda, (unknown), Hideki Tani, Hideki Niimi, Yoshitomo Morinaga, Kyo Noguchi, Yoshihiro Yamamoto	1
12	Predictive values of immune indicators on respiratory failure in the early phase of COVID-19 due to Delta and precedent variants 2023 ·Frontiers in Immunology ·Kentaro Nagaoka, Hitoshi Kawasuji, (unknown), Y Murai, Makito Kaneda, (unknown), Shimpei Morimoto, (unknown), Hideki Niimi, Yoshitomo Morinaga, Yoshihiro Yamamoto	3
13	High Incidence of Metastatic Infections in Panton-Valentine Leucocidin-Negative, Community-Acquired Methicillin-Resistant Staphylococcus aureus Bacteremia: An 11-Year Retrospective Study in Japan 2023 ·Antibiotics ·Hitoshi Kawasuji, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Makito Kaneda, (unknown), Kentaro Nagaoka, Hideki Niimi, Yoshitomo Morinaga, Yoshihiro Yamamoto	1
14	Association of subpleural ground-glass opacities with respiratory failure and RNAemia in COVID-19 2023 ·European Radiology ·Kentaro Nagaoka, Hitoshi Kawasuji, (unknown), (unknown), Makito Kaneda, Akitoshi Ueno, Yuki Miyajima, (unknown), Kyo Noguchi, (unknown), Yoshitomo Morinaga, Yoshihiro Yamamoto	5
15	Effectiveness and Safety of Linezolid Versus Vancomycin, Teicoplanin, or Daptomycin against Methicillin-Resistant Staphylococcus aureus Bacteremia: A Systematic Review and Meta-Analysis 2023 ·Antibiotics ·Hitoshi Kawasuji, Kentaro Nagaoka, Yasuhiro Tsuji, (unknown), (unknown), Makito Kaneda, (unknown), (unknown), Kotaro Mitsutake, Yoshihiro Yamamoto	24
16	Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure 2022 ·Frontiers in Immunology ·Kentaro Nagaoka, Hitoshi Kawasuji, (unknown), Makito Kaneda, Akitoshi Ueno, Yuki Miyajima, Yasutaka Fukui, Yoshitomo Morinaga, Yoshihiro Yamamoto	14
17	Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein 2021 ·Virology Journal ·Hideki Tani, Miyuki Kimura, Long Tan, Yoshihiro Yoshida, Tatsuhiko Ozawa, Hiroyuki Kishi, Shuetsu Fukushi, Masayuki Saijo, Kaori Sano, Tadaki Suzuki, Hitoshi Kawasuji, Akitoshi Ueno, Yuki Miyajima, Yasutaka Fukui, Ippei Sakamaki, Yoshihiro Yamamoto, Yoshitomo Morinaga	37
18	Classification Tree Analysis Based On Machine Learning for Predicting Linezolid-Induced Thrombocytopenia 2021 ·Journal of Pharmaceutical Sciences ·(unknown), Yasuhiro Tsuji, Hidefumi Kasai, Chika Ogami, Hitoshi Kawasuji, Yoshihiro Yamamoto, Hideto To	8
19	Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19 2021 ·Scientific Reports ·Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Miyuki Kimura, Hiroshi Yamada, Yoshihiro Yoshida, (unknown), Makito Kaneda, (unknown), (unknown), Akitoshi Ueno, Yuki Miyajima, (unknown), Yasutaka Fukui, Ippei Sakamaki, Yoshihiro Yamamoto	8
20	Congenital tuberculosis in an extremely preterm infant and prevention of nosocomial infection 2019 ·Journal of Infection and Chemotherapy ·Kentaro Tamura, Hitoshi Kawasuji, (unknown), (unknown), (unknown), (unknown), Ippei Sakamaki, Yoshihiro Yamamoto, (unknown), Junko Isobe, Satoshi Mitarai, Noriko Yoneda, Satoshi Yoneda, Shigeru Saito, Taketoshi Yoshida	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact